Clinical Trial Update: Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies

View source ↗

Summary

An update on an exploratory study evaluating the reparative and regenerative potential of alemtuzumab in relapsing-remitting multiple sclerosis patients enrolle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Alemtuzumab (Lemtrada) (alemtuzumab)

Snippet

Sponsor: Wayne State University | Conditions: Multiple Sclerosis | Status: COMPLETED